News
Biden’s COVID-19 challenge: 100 million vaccinations in the first 100 days. It won’t be easy.
January 20, 2021
“I think it’s an attainable goal. I think it’s going to be extremely challenging,” said Claire Hannan, executive director of the Association of Immunization Managers.
![1]()
News
Many EM docs have treated COVID-19 patients without proper PPE: Survey
January 20, 2021
More than half of EM physicians (54%) said that they had knowingly taken personal safety risks to treat a COVID-19 emergency.
News
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
January 19, 2021
Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.
![1]()
News
COVID-19 in children: Latest weekly increase is largest yet
January 19, 2021
The total number reported during Jan. 8-14 topped the previous high by almost 30,000 cases.
News
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
January 19, 2021
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying best candidates for SGLT2 inhibitor therapy, some say.
![1]()
News
HHS will drop buprenorphine waiver rule for most physicians
January 19, 2021
There were more than 83,000 deaths attributed to drug overdoses in the United States in the 12 months ending in June 2020.
![1]()
News
Covert stroke after noncardiac surgery linked with cognitive decline
January 19, 2021
Does covert stroke increase the risk of cognitive decline after noncardiac surgery in patients older than 65 years?
![1]()
News
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
January 15, 2021
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
News
Long-haul COVID-19 cases rise as stigma of chronic fatigue taunts
January 15, 2021
An estimated three-quarters of all patients with chronic fatigue syndrome report that their symptoms started after a viral infection.
News
The next likely COVID-19 vaccine has its advantages
January 15, 2021
A single Ad26.COV2.S dose was associated with S-binding and neutralizing antibodies in more than 90% of the participants.
